These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32153661)

  • 1. OK-Flow. Sorry - No-Reflow.
    Cinteza M
    Maedica (Bucur); 2019 Dec; 14(4):323-325. PubMed ID: 32153661
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
    Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
    Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Slow-Flow After Primary Percutaneous Coronary Intervention With Flow-Mediated Hyperemia: The Randomized RAIN-FLOW Study.
    Gomez-Lara J; Gracida M; Rivero F; Gutiérrez-Barrios A; Muntané-Carol G; Romaguera R; Fuentes L; Marcano A; Roura G; Ferreiro JL; Teruel L; Brugaletta S; Alfonso F; Comín-Colet J; Gomez-Hospital JA
    J Am Heart Assoc; 2023 Jul; 12(13):e030285. PubMed ID: 37345805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after acute reperfused myocardial infarction.
    Leclercq F; Messner-Pellenc P; Descours Q; Daures JP; Pasquié JL; Hager FX; Davy JM; Grolleau-Raoux R
    Heart; 1999 Jul; 82(1):62-7. PubMed ID: 10377311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrupt reflow enhances cytokine-induced proinflammatory activation of endothelial cells during simulated shock and resuscitation.
    Li R; Zijlstra JG; Kamps JA; van Meurs M; Molema G
    Shock; 2014 Oct; 42(4):356-64. PubMed ID: 25051282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.
    Li J; Wu L; Tian X; Zhang J; Shi Y
    PLoS One; 2015; 10(6):e0119223. PubMed ID: 26035818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis.
    Savic L; Mrdovic I; Asanin M; Stankovic S; Lasica R; Krljanac G; Rajic D; Simic D
    J Interv Cardiol; 2022; 2022():5815274. PubMed ID: 36531287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of reactive hyperemia after coronary recanalization on myocardial tissue reperfusion by thrombolysis in myocardial infarction flow grade in acute myocardial infarction.
    Okamura A; Ito H; Iwakura K; Kawano S; Kurotobi T; Date M; Inoue K; Ogihara T; Fujii K
    Am J Cardiol; 2006 Mar; 97(5):617-23. PubMed ID: 16490424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between endothelial dysfunction and occurrence of no-reflow in patients undergoing post-thrombolysis early invasive percutaneous intervention for ST-elevation myocardial infarction.
    Elbendary MAW; Saleh MA; Sabet SS; Bastawy I
    Egypt Heart J; 2022 Sep; 74(1):70. PubMed ID: 36178560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Li Q; Xie E; Tu Y; Wu Y; Guo Z; Li P; Li Y; Yu X; Ye Z; Yu C; Gao Y; Jingang Z
    Int J Cardiol; 2022 Dec; 369():13-18. PubMed ID: 35970443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction.
    Kalyoncuoglu M; Biter Hİ; Ozturk S; Belen E; Can MM
    Coron Artery Dis; 2020 Sep; 31(6):518-526. PubMed ID: 32040024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction.
    Iwakura K; Ito H; Takiuchi S; Taniyama Y; Nakatsuchi Y; Negoro S; Higashino Y; Okamura A; Masuyama T; Hori M; Fujii K; Minamino T
    Circulation; 1996 Sep; 94(6):1269-75. PubMed ID: 8822979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage.
    Villanueva FS; Glasheen WP; Sklenar J; Kaul S
    Circulation; 1993 Dec; 88(6):2596-606. PubMed ID: 8252670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraaortic balloon pumping on the angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction.
    Maekawa K; Kawamoto K; Fuke S; Yoshioka R; Saito H; Sato T; Hioka T
    Circ J; 2006 Jan; 70(1):37-43. PubMed ID: 16377922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Allaithy A; Maria DA
    Anatol J Cardiol; 2022 May; 26(5):382-387. PubMed ID: 35552174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.
    Hillegass WB; Dean NA; Liao L; Rhinehart RG; Myers PR
    J Am Coll Cardiol; 2001 Apr; 37(5):1335-43. PubMed ID: 11300444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.